ArticleOncoTargets and therapy2021

A Novel KIF5B-EGFR Fusion Variant in Non-Small-Cell Lung Cancer and Response to Afatinib: A Case Report.

Xia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.